The effect of daily co-trimoxazole prophylaxis on natural development of antibody-mediated immunity against P. falciparum malaria infection in HIV-exposed uninfected Malawian children

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Longwe, Herbert ^a   Jambo, Kondwani C ^a   Phiri, Kamija S ^a   Mbeye, Nyanyiwe ^a   Gondwe, Thandile ^a   Hall, Tom ^b   Tetteh, Kevin K A ^b   Drakeley, Chris ^b   Mandala, Wilson L ^a  

^a UNIVERSITY OF MALAWI   (Malawi)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; CIRCUMSPOROZOITE PROTEIN; COTRIMOXAZOLE; ERYTHROCYTE BINDING ANTIGEN 175 REGION II; GLUTAMATE RICH PROTEIN FRAGMENT; IMMUNOGLOBULIN G; MEROZOITE SURFACE PROTEIN 1 19; MEROZOITE SURFACE PROTEIN 3; PARASITE ANTIGEN; PFSE ANTIGEN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; INFANT; INNATE IMMUNITY; MALARIA CONTROL; MALARIA FALCIPARUM; MALAWIAN; MALE; ACTIVE IMMUNIZATION; ANTIBIOTIC PROPHYLAXIS; ANTIBODY PRODUCTION; DRUG EFFECTS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALARIA, FALCIPARUM; MALAWI;

PLASMODIUM FALCIPARUM;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTIBODY FORMATION; FEMALE; HIV INFECTIONS; HUMANS; IMMUNITY, ACTIVE; IMMUNOGLOBULIN G; INFANT; MALARIA, FALCIPARUM; MALAWI; MALE; TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION;

EID: 84926369050     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121643     Document Type: Article

References (53)

1. Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, et al. (2012) Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379: 413-431. doi: 10.1016/S0140-6736(12)60034-8 PMID: 22305225
2. WHO (2012) World Malaria Report. Geneva: World Health Organization
3. Greenwood B, Marsh K, Snow R (1991) Why do some African children develop severe malaria? Parasitol Today 7: 277-281. PMID: 15463389
4. Riley EM (1999) Is T-cell priming required for initiation of pathology in malaria infections? Immunol Today 20: 228-233. PMID: 10322302
5. Artavanis-Tsakonas K, Tongren JE, Riley EM (2003) The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Clin Exp Immunol 133: 145-152. PMID: 12869017
6. Cohen S, Mc GI, Carrington S (1961) Gamma-globulin and acquired immunity to human malaria. Nature 192: 733-737. PMID: 13880318
7. Sabchareon A, Burnouf T, Ouattara D, Attanath P, Bouharoun-Tayoun H, et al. (1991) Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg 45: 297-308. PMID: 1928564
8. Marsh K, Kinyanjui S (2006) Immune effector mechanisms in malaria. Parasite Immunol 28: 51-60. PMID: 16438676
9. Langhorne J, Ndungu FM, Sponaas AM, Marsh K (2008) Immunity to malaria: more questions than answers. Nat Immunol 9: 725-732. doi: 10.1038/ni.f.205 PMID: 18563083
10. Persson KE (2010) Erythrocyte invasion and functionally inhibitory antibodies in Plasmodium falciparum malaria. Acta Trop 114: 138-143. doi: 10.1016/j.actatropica.2009.05.017 PMID: 19481996
11. Wright GJ, Rayner JC (2014) Plasmodium falciparum erythrocyte invasion: combining function with immune evasion. PLoS Pathog 10: e1003943. doi: 10.1371/journal.ppat.1003943 PMID: 24651270
12. Dobano C, Quelhas D, Quinto L, Puyol L, Serra-Casas E, et al. (2012) Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children. Clin Vaccine Immunol 19: 157-166. doi: 10.1128/CVI.05523-11 PMID: 22169088
13. Dodoo D, Atuguba F, Bosomprah S, Ansah NA, Ansah P, et al. (2011) Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana. Malar J 10: 108. doi: 10.1186/1475-2875-10-108 PMID: 21529376
14. Ndungu FM, Bull PC, Ross A, Lowe BS, Kabiru E, et al. (2002) Naturally acquired immunoglobulin (Ig) G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2. Parasite Immunol 24: 77-82. PMID: 11874562
15. Okenu DM, Riley EM, Bickle QD, Agomo PU, Barbosa A, et al. (2000) Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum. Infect Immun 68: 5559-5566. PMID: 10992454
16. Bwakura-Dangarembizi M, Kendall L, Bakeera-Kitaka S, Nahirya-Ntege P, Keishanyu R, et al. (2014) A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa. N Engl J Med 370: 41-53. doi: 10.1056/NEJMoa1214901 PMID: 24382064
17. Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, et al. (2004) Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 364: 1428-1434. PMID: 15488218
18. Mulenga V, Ford D, Walker AS, Mwenya D, Mwansa J, et al. (2007) Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children. AIDS 21: 77-84. PMID: 17148971
19. WHO (2006) Guidelines on Co-Trimoxazole Prophylaxis for HIV-Related Infections Among Children, Adolescents and Adults. Recommendations for a Public Health Approach. Geneva: World Health Organization.
20. Hamel MJ, Holtz T, Mkandala C, Kaimila N, Chizani N, et al. (2005) Efficacy of trimethoprim-sulfamethoxazole compared with sulfadoxine-pyrimethamine plus erythromycin for the treatment of uncomplicated malaria in children with integrated management of childhood illness dual classifications of malaria and pneumonia. Am J Trop Med Hyg 73: 609-615. PMID: 16172491
21. Mbeye NM, ter Kuile FO, Davies MA, Phiri KS, Egger M, et al. (2014) Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health 19: 1057-1067. doi: 10.1111/tmi.12352 PMID: 25039469
22. Aponte JJ, Menendez C, Schellenberg D, Kahigwa E, Mshinda H, et al. (2007) Age interactions in the development of naturally acquired immunity to Plasmodium falciparum and its clinical presentation. PLoS Med 4: e242. PMID: 17676985
23. Greenwood BM, David PH, Otoo-Forbes LN, Allen SJ, Alonso PL, et al. (1995) Mortality and morbidity from malaria after stopping malaria chemoprophylaxis. Trans R Soc Trop Med Hyg 89: 629-633. PMID: 8594677
24. Menendez C, Kahigwa E, Hirt R, Vounatsou P, Aponte JJ, et al. (1997) Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 350: 844-850. PMID: 9310602
25. Bousema T, Drakeley C, Gesase S, Hashim R, Magesa S, et al. (2010) Identification of hot spots of malaria transmission for targeted malaria control. J Infect Dis 201: 1764-1774. doi: 10.1086/652456 PMID: 20415536
26. Rantala AM, Taylor SM, Trottman PA, Luntamo M, Mbewe B, et al. (2010) Comparison of real-time PCR and microscopy for malaria parasite detection in Malawian pregnant women. Malar J 9: 269. doi: 10.1186/1475-2875-9-269 PMID: 20925928
27. Collins CR, Withers-Martinez C, Bentley GA, Batchelor AH, Thomas AW, et al. (2007) Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen 1. J Biol Chem 282: 7431-7441. PMID: 17192270
28. Burghaus PA, Holder AA (1994) Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. Mol Biochem Parasitol 64: 165-169. PMID: 8078519
29. Pandey KC, Singh S, Pattnaik P, Pillai CR, Pillai U, et al. (2002) Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies. Mol Biochem Parasitol 123: 23-33. PMID: 12165386
30. Tsai CW, Duggan PF, Jin AJ, Macdonald NJ, Kotova S, et al. (2009) Characterization of a protective Escherichia coli-expressed Plasmodium falciparum merozoite surface protein 3 indicates a non-linear, multi-domain structure. Mol Biochem Parasitol 164: 45-56. doi: 10.1016/j.molbiopara.2008.11.006 PMID: 19073223
31. Kastenmuller K, Espinosa DA, Trager L, Stoyanov C, Salazar AM, et al. (2013) Full-length Plasmodium falciparum circumsporozoite protein administered with long-chain poly(I.C) or the Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant-stable emulsion elicits potent antibody and CD4+ T cell immunity and protection in mice. Infect Immun 81: 789-800. doi: 10.1128/IAI.01108-12 PMID: 23275094
32. Theisen M, Vuust J, Gottschau A, Jepsen S, Hogh B (1995) Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli. Clin Diagn Lab Immunol 2: 30-34. PMID: 7719909
33. Holder AA, Freeman RR (1982) Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody. J Exp Med 156: 1528-1538. PMID: 6752328
34. Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, et al. (2005) Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A 102: 5108-5113. PMID: 15792998
35. Nyirenda TS, Gilchrist JJ, Feasey NA, Glennie SJ, Bar-Zeev N, et al. (2014) Sequential acquisition of T cells and antibodies to nontyphoidal Salmonella in Malawian children. J Infect Dis 210: 56-64. PMID: 24443544
36. Kusi KA, Bosomprah S, Dodoo D, Kyei-Baafour E, Dickson EK, et al. (2014) Anti-sporozoite antibodies as alternative markers for malaria transmission intensity estimation. Malar J 13: 103. doi: 10.1186/1475-2875-13-103 PMID: 24635830
37. Boulanger D, Sarr JB, Fillol F, Sokhna C, Cisse B, et al. (2010) Immunological consequences of intermittent preventive treatment against malaria in Senegalese preschool children. Malar J 9: 363. doi: 10.1186/1475-2875-9-363 PMID: 21167018
38. Ibison F, Olotu A, Muema DM, Mwacharo J, Ohuma E, et al. (2012) Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya. PLoS One 7: e52939. doi: 10.1371/journal.pone.0052939 PMID: 23300828
39. Proietti C, Verra F, Bretscher MT, Stone W, Kanoi BN, et al. (2013) Influence of infection on malaria-specific antibody dynamics in a cohort exposed to intense malaria transmission in northern Uganda. Parasite Immunol 35: 164-173. doi: 10.1111/pim.12031 PMID: 23473542
40. Kinyanjui SM, Conway DJ, Lanar DE, Marsh K (2007) IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar J 6: 82. PMID: 17598897
41. Moncunill G, Mayor A, Jimenez A, Nhabomba A, Casas-Vila N, et al. (2013) High antibody responses against Plasmodium falciparum in immigrants after extended periods of interrupted exposure to malaria. PLoS One 8: e73624. doi: 10.1371/journal.pone.0073624 PMID: 23967347
42. Osier FH, Fegan G, Polley SD, Murungi L, Verra F, et al. (2008) Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun 76: 2240-2248. doi: 10.1128/IAI.01585-07 PMID: 18316390
43. Rono J, Osier FH, Olsson D, Montgomery S, Mhoja L, et al. (2013) Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria. Clin Infect Dis 57: 1409-1416. doi: 10.1093/cid/cit556 PMID: 23983244
44. Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, et al. (2011) Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA 305: 576-584. doi: 10.1001/jama.2011.100 PMID: 21304083
45. Gordon MA, Graham SM (2008) Invasive salmonellosis in Malawi. J Infect Dev Ctries 2: 438-442. PMID: 19745520
46. Gordon MA, Graham SM, Walsh AL, Wilson L, Phiri A, et al. (2008) Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin Infect Dis 46: 963-969. doi: 10.1086/529146 PMID: 18444810
47. Haeusler GM, Curtis N (2013) Non-typhoidal Salmonella in children: microbiology, epidemiology and treatment. Adv Exp Med Biol 764: 13-26. PMID: 23654054
48. Albrecht P, Ennis FA, Saltzman EJ, Krugman S (1977) Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J Pediatr 91: 715-718. PMID: 909009
49. al-Yaman F, Genton B, Kramer KJ, Chang SP, Hui GS, et al. (1996) Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity. Am J Trop Med Hyg 54: 443-448. PMID: 8644896
50. Dodoo D, Theander TG, Kurtzhals JA, Koram K, Riley E, et al. (1999) Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria. Infect Immun 67: 2131-2137. PMID: 10225865
51. Greenhouse B, Ho B, Hubbard A, Njama-Meya D, Narum DL, et al. (2011) Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic. J Infect Dis 204: 19-26. doi: 10.1093/infdis/jir223 PMID: 21628654
52. Mugyenyi CK, Elliott SR, McCallum FJ, Anders RF, Marsh K, et al. (2013) Antibodies to polymorphic invasion-inhibitory and non-Inhibitory epitopes of Plasmodium falciparum apical membrane antigen 1 in human malaria. PLoS One 8: e68304. doi: 10.1371/journal.pone.0068304 PMID: 23861883
53. Ogutu BR, Apollo OJ, McKinney D, Okoth W, Siangla J, et al. (2009) Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya. PLoS One 4: e4708. doi: 10.1371/journal.pone.0004708 PMID: 19262754